Company: NAVN
Filing Date: 2025-10-10
Form Type: S-1/A
Source: 0001628280-25-044812
Chunk: 376

Company: Navan, Inc.
Filing Date: 2025-10-10
Form: S-1/A
Chunk 376
---
5 |     |       2024 |
|:------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------:|:----|-----------:|
| Net loss.....................................................................................................................                               |             $(181,078) |     | $(331,552) |
| Weighted-average shares outstanding used to compute net loss per shareattributable to common stockholders, basic and diluted............................... |             45,271,666 |     | 44,583,919 |
| Net loss per share attributable to common stockholders, basic and diluted.                                                                                  |                $(4.00) |     |    $(7.44) |

During the years ended January 31, 2025 and 2024, the Company was in a net loss position. As a result, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential shares of common stock outstanding would have been antidilutive. The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:

|                                                                                                                       | As of January 31, |     |             |
|                                                                                                                       |              2025 |     |        2024 |
| Redeemable convertible preferred shares..........................................................                     |       146,360,207 |     | 146,360,207 |
| Stock options issued and outstanding.................................................................                 |        40,971,097 |     |  41,769,970 |
| RSUs issued and outstanding...............................................................................            |         4,653,847 |     |     948,938 |
| Warrants to purchase redeemable convertible preferred stock......................                                     |            40,160 |     |      40,160 |
| Shares of common stock subject to repurchase................................................                          |            49,761 |     |     133,332 |
| Convertible notes.................................................................................................... |        12,946,170 |     |  13,980,833 |
| Total antidilutive securities....................................................................................     |       205,021,242 |     | 203,233,440 |

NOTE 16 – SUBSEQUENT EVENTS During the three months ended April 30, 2025, we issued a term loan and common stock warrants in exchange for cash proceeds of $130.0 million, and also executed Simple Agreements for Future Equity (“SAFEs”) and common stock warrants in